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Staphylococcus aureus is a common cause of intramammary infections, which frequently become chronic,
associated with the ability of the bacteria to produce biofilm. Here, we report a relationship between the ability
to produce chronic bovine mastitis and biofilm formation. We have classified bovine mastitis S. aureus isolates
into three groups based on the presence of particular genetic elements required for biofilm formation: group
1 (ica bap), group 2 (ica, bap negative), and group 3 (ica negative, bap negative). Overall, animals naturally
infected with group 1 and 2 isolates had a lower milk somatic cell count than those infected with isolates of
group 3. In addition, Bap-positive isolates were significantly more able to colonize and persist in the bovine
mammary gland in vivo and were less susceptible to antibiotic treatments when forming biofilms in vitro.
Analysis of the structural bap gene revealed the existence of alternate forms of expression of the Bap protein
in S. aureus isolates obtained under field conditions throughout the animal’s life. The presence of anti-Bap
antibodies in serum samples taken from animals with confirmed S. aureus infections indicated the production
of Bap during infection. Furthermore, disruption of the ica operon in a bap-positive strain had no effect on in
vitro biofilm formation, a finding which strongly suggested that Bap could compensate for the deficiency of the
PIA/PNAG product (a biofilm matrix polysaccharide). Altogether, these results demonstrate that, in the bovine
intramammary gland, the presence of Bap may facilitate a biofilm formation connected with the persistence of
S. aureus.
The gram-positive bacterium Staphylococcus aureus is an
adaptable, opportunistic pathogen whose ability to persist and
multiply in a variety of environments causes a wide spectrum of
diseases in both humans and animals. In humans, S. aureus is
the causative agent of many infections, ranging from superficial
skin suppurations to life-threatening septicemias associated
with visceral or bone infections. Successful treatment is often
hindered by the increasing prevalence of methicillin-resistant
strains and by antibiotic inefficacy against the bacteria involved
in chronic infections.
In lactating animal females, S. aureus is a common cause of
intramammary infections (IMI), frequently leading to chronic
mastitis. Because this type of infection is very difficult to erad-
icate with antibiotic therapy, a premature culling of animals,
involving substantial production losses, is the only efficient
strategy to control this type of mastitis. S. aureus IMI is usually
initiated either by colonization of the teat canal with bacteria
derived from infected epidermis or by an influx of contami-
nated milk entering the gland, a problem due to such deficient
management practices as a poorly adjusted vacuum in milking
machines. Bacteria adapt and multiply in the milk, gaining
access to the upper part of the gland. It has been proposed that
bacteria adhere to the ductular and alveolar epithelium in the
gland and begin production of toxins. These adhered bacteria
trigger macrophage activation and neutrophil migration from
the blood into the milk (a situation resulting in an increase in
the somatic cell count [SCC]), inflammation of the mammary
gland, impairment of the host immune system, and epithelial
cell damage. As a result, bacteria reach the basal subepithelial
cell layers, bind fibrinogen and other host receptor proteins,
and finally establish an infection which often becomes chronic
(14).
Many chronic infections are associated with a bacterial
growth in the form of adherent colonies surrounded by a large
exopolysaccharide matrix, constituting a biofilm (for reviews,
see references 5, 6, and 11). Because of their aggregate size,
biofilms are not susceptible to macrophage phagocytosis and
become resistant to some antibiotics (2, 29, 30).
The implication of biofilms in chronic infections has trig-
gered an increasing interest in the characterization of genes
involved in biofilm formation (15). The icaADBC cluster, an
operon present in Staphylococcus epidermidis (18) and S. au-
reus (7), participates in biofilm formation by encoding proteins
involved in the synthesis of a biofilm matrix polysaccharide
(named PIA/PNAG) composed of linear -1-6-linked
N-acetylglucosamine residues (23, 25). Recently, we have iden-
tified a surface protein, Bap (for biofilm associated protein),
also implicated in bovine S. aureus biofilm formation (8). The
bap gene encodes a large protein of 2,276 amino acids (aa) and
promotes both primary attachment to inert surfaces and inter-
cellular adhesion; in contrast, PIA/PNAG seems to be mainly
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involved in intercellular adhesion. Bap is structurally related to
the alpha C protein of group B streptococci and has a core C
region (aa 948 to 2139) consisting of 13 identical 258-nucleo-
tide tandem repeat units encoding reiterations of an 86-aa
sequence (C repeats). The C repeat region accounts for 52% of
the Bap protein, and each repeat unit shows a high sequence
identity with other repeat units of this protein. The bap gene is
contained in a mobile pathogenicity island (35), and so far it
has only been found in bovine mastitis isolates.
The purpose of this study was to investigate whether biofilm
production in S. aureus strains from bovine mastitis is a patho-
genic factor contributing to that mastitis. We report that bap-
positive S. aureus strains show an elevated capacity to infect
and persist in the mammary gland. Further, we find that,
throughout the course of an infection, Bap frequently under-
goes changes in the number of repeats within the C repeat
region.
MATERIALS AND METHODS
Bacterial isolates. S. aureus isolates were collected from 195 subclinical mas-
titis-infected cows belonging to 13 dairy herds of the Spanish province of Va-
lencia. One herd (herd E) was involved in a longitudinal survey of the population
dynamics of IMI. In this herd, milk samples were collected at 3-month intervals
from udders which were found to be naturally infected with S. aureus and which
yielded milk with a high SCC. In this farm, milk was also collected on two
occasions from all the animals, independent of their SCC score. Bacteria were
cultured from the milk samples according to National Mastitis Council standards
(16) and were identified as S. aureus by standard procedures, including Gram
staining, catalase and coagulase tests (22), and API-Staph (bioMerieux) and
were stored at80°C until use. The criteria we established to consider an animal
as infected was the isolation from that animal of the same clonal type of S. aureus
in two consecutive milk samples. For comparison, 50 clinical human isolates from
Valencia were analyzed.
For determination of antibiotic resistance, four representative bovine S. aureus
isolates from herd E were chosen: V329 (highly adherent and with a rough
colony morphology on Congo red agar), harboring the bap and icaADBC genes
(8); m556, an isogenic transposon insertional Bap-mutant of V329, with a smooth
colony morphology on Congo red agar and harboring icaADBC (8); V299 (a
bap-negative icaADBC-positive strain); and V315 (a bap-negative and icaADBC-
negative strain).
The criterion applied to detect subclinical mastitis was based on the SCC
obtained with a Fossomatic 90 cell counter (A/S N Foss Electric, Hillerød,
Denmark). The threshold between noninfected and infected was set at 200,000
cells/ml (10), a low threshold established to avoid false-negative results. Based on
SCC, isolates were classified into four categories: category A, very low SCC
(200 103 cells/ml); category B, low-medium SCC (between 200 103 and 750
 103 cells/ml); category C, high SCC (between 750  103 and 1,500  103
cells/ml); and category D, very high SCC (over 1,500  103 cells/ml). The
California mastitis test (CMT) was also performed regularly as a control for
mastitis diagnosis in the field.
Molecular typing of S. aureus strains. PCR amplification of the coa gene was
performed as previously described (20). Briefly, the oligonucleotides coa-1m
(5-ATAGAGATGCTGGTACAGG-3) and coa-2c (5-GCTTCCGATTGTTC
GATGC-3), encompassing the entire 3 repeats, were utilized. Each amplifica-
tion comprised 100 ng of DNA template, 100 pmol of each primer, 200 M
(each) deoxynucleoside triphosphates (dATP, dGTP, dCTP, and dTTP), 1
buffer (Netzyme), 1 mM MgCl2, and 1 U of thermostable DNA polymerase
(Netzyme). Water was added to a final volume of 25 l, and thermal cycling was
performed as outlined in reference 20. An initial denaturation step at 94°C for 2
min was followed by 30 cycles of 94°C for 20 s, 57°C for 15 s, and 72°C for 30 s,
with a final step at 72°C for 5 min. The size of the PCR products (5-l aliquot)
was analyzed by electrophoresis on 1% (wt/vol) agarose gels.
Restriction endonuclease analysis of the PCR-amplified coa gene was per-
formed as previously described (20). Approximately 500 ng of PCR product was
digested with 5 U of restriction endonuclease CfoI (Roche) at 37°C for 2 h and
analyzed by electrophoresis on 3% (wt/vol) agarose gels.
Analysis of genes involved in biofilm formation. S. aureus chromosomal DNA
was extracted using standard procedures (32). For PCR analysis, two pairs of
primers were designed for amplifications of fragments of the ica and bap genes
of S. aureus. The ica primers (icaH-1m, 5-TATACCTTTCTTCGATGTCG-3;
icaH-7c, 5-CTTTCGTTATAACAGGCAAG-3) were designed to amplify part
of the icaR and icaA genes of the icaADBC locus. For amplification of the bap
gene (AF288402), primers sasp-6m (5-CCCTATATCGAAGGTGTAGAATT
GCAC-3) and sasp-7c (5-GCTGTTGAAGTTAATACTGTACCTGC-3) were
utilized. Each PCR was performed in duplicate. The DNA amplifications were
carried out using the same procedure as in the molecular typing of the S. aureus
strains; the thermal cycling profile consisted of an initial denaturation at 94°C for
2 min, 40 cycles of 94°C for 20 s, 42°C for 20 s, and 72°C for 50 s, with a final step
at 72°C for 5 min. The size of the PCR products was analyzed by electrophoresis
on 0.8% (wt/vol) agarose gels.
For Southern blot hybridization, chromosomal DNA digested with EcoRI was
analyzed by agarose gel electrophoresis. Gels were blotted onto nylon mem-
branes (Hybond-N [0.45-mm-pore-size filters]; Amersham Life Science) using
standard methods (32). The PCR product of the amplified ica region was used as
a DNA probe. Labeling of the probe and DNA hybridization were performed
according to the protocol supplied with the PCR-DIG DNA-labeling and chemi-
luminescent detection kit (Roche).
Homologous recombination. Wild-type S. aureus V329 containing plasmid
pSC23 (7) was grown overnight in B medium at 30°C with chloramphenicol (10
g/ml), diluted 1:1,000, grown again at 30°C with antibiotic selection, diluted
1:1,000, and grown at 42°C without antibiotic selection twice, diluted 1:100, and
plated on tryptone soy agar (Difco) plates containing tetracycline (2.5 g/ml).
Homologous recombination and plasmid curing of the chloramphenicol-sensi-
tive, tetracycline-resistant colonies were then confirmed by PCR and Southern
blotting.
Biofilm formation. The quantification of biofilm formation on abiotic surfaces
was assessed basically as described elsewhere (17). Briefly, S. aureus was grown
overnight in tryptone soy broth (TSB) (Difco) supplemented with 0.25% glucose
(TSB-glucose). The culture was diluted 1:40 in TSB-glucose, and 200 l of this
cell suspension was used per well to inoculate sterile, 96-well polystyrene micro-
titer plates (Iwaki). After 18 h of incubation at 37°C, the wells were gently
washed three times with 200 l of sterile phosphate-buffered saline (PBS), air
dried in an inverted position, and stained with 0.1% safranin for 30 s. The wells
were rinsed again, and the absorbance was determined at 490 nm (Micro-ELISA
Autoreader Elx800; Bio-Tek Instruments). Each assay was performed in tripli-
cate in five separate experiments.
Colony morphology was studied on Congo red agar as previously described
(4). A positive result (biofilm formation) was indicated by the presence of black
or pink colonies with a dry crystalline surface (rough colony phenotype). A
deficiency in biofilm formation was indicated by the presence of smooth colonies.
Classical antibiotic susceptibility assays. The resistance profile (MIC and
minimal bactericidal concentration [MBC]) was determined for each isolate by a
broth microdilution method, following the recommendations of the National
Committee for Clinical Laboratory Standards (31), and the concentration theo-
retically reached in serum (peak in serum [PS]) was obtained taking as reference
the values described by Mensa (27). The three concentrations (MIC, MBC, and
PS) were used in the antibiotic susceptibility assay for bacteria in biofilms.
Antibiotic susceptibility assay for bacteria in biofilms. Following a previously
outlined procedure to produce the biofilms (30), 25 l of stationary-phase bac-
terial cell cultures grown in TSB (Difco, Detroit) were added to flat-bottom
microtiter wells (Iwaki) containing 175 l of TSB enriched with 2% glucose (2).
An incubation period of 6 or 24 h at 37°C followed, depending upon the desired
biofilm age; for the 24-h biofilm, the growth medium was renewed at 12 h. After
washing the biofilms with distilled water to remove free bacteria, 100 l of
antibiotic and 100 l of Mueller-Hinton broth were added to finally reach the
concentrations specified above (MIC, MBC, and PS). Six antibiotics were tested:
cefazolin, cefuroxime, rifampin, tobramycin, vancomycin (Sigma), and cipro-
floxacin (Bayer). These antibiotics had been resuspended, diluted in water, filter
sterilized (pore size, 0.22 m), and stored at 4°C before testing. After a 24-h
exposure of the biofilm to the antibiotic at 37°C, the supernatant was discarded
and viable bacteria were quantified by ATP-bioluminescence (2). Tests were
done in triplicate and on three different occasions. Samples not treated with
antibiotics were included as controls.
Adhesion to epithelial cells. Cellular studies were performed by well-known
methods (12). An established epithelial cell line, designated 293 (ATCC CRL-
1573), was used for all experiments. The 293 cells were grown in Dulbecco’s
modified Eagle medium (Invitrogen Life Technologies) containing 10% fetal
bovine serum (Invitrogen Life Technologies), 100 U of penicillin G/ml, and 100
g of streptomycin sulfate/ml (Invitrogen Life Technologies). Prior to use, the
cells were seeded at 6 104 cells/well and grown for 3 days at 37°C with 5% CO2.
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For the adhesion assays, the cells were grown in 24-well tissue culture plates
(Iwaki).
Approximately 16 h prior to the adhesion experiments the 293 cell growth
medium was replaced with 0.5 ml of adhesion medium (growth medium without
antibiotics or fetal bovine serum). The morning of the experiment, the medium
was removed, and the 293 cells were washed once with adhesion medium and
given 0.5 ml of fresh adhesion medium. Appropriate wells of 293 cells were then
inoculated with 106 CFU of washed S. aureus and incubated at 37°C with 5%
CO2. After 2 h, supernatants of the cocultures were removed; the 293 cell
monolayers were washed three times with sterile PBS, and further lysed with
0.025% Triton X-100 (Sigma) in sterile distilled water. The cell lysates were
serially diluted 10-fold and plated in triplicate on tryptone soy agar plates; the
plates were incubated overnight at 37°C, and the CFU were counted. The results
of representative experiments are described.
Repeat number variation in the C region of the bap gene. To assess the repeat
number variation in the C region of the bap gene, primers sasp-6m and sasp-9c
(5-CTCTCCACCTTTGTAAGTGGAGAGCC-3) were used to amplify across
the C repeat region of the bap gene. Briefly, 25 l of the PCR mixture consisted
of 250 ng of DNA; a 0.2 M concentration of each of the forward and reverse
primers; a 200 M concentration each of dATP, dCTP, dGTP, and dTTP; 2.5
mM MgCl2; and 2.5 U of DyNAzyme EXT (Finnzymes) in a 1 reaction buffer.
After an initial denaturation step at 95°C for 4 min, the mixture was subjected to
40 cycles of denaturation (at 94°C for 30 s), annealing (at 54°C for 30 s), and
extension (at 72°C for 5 min). One-tenth of the amplified reaction mixture was
mixed with a gel-loading buffer and electrophoresed on a 0.8% (wt/vol) agarose
gel; the reaction products were visualized by ethidium bromide staining.
In order to confirm that the different size observed was a consequence of a
different C repeat number, a restriction endonuclease analysis of the PCR-
amplified product was performed. Approximately 500 ng of the PCR product was
digested with 5 U of the restriction endonuclease PstI (Roche) at 37°C for 2 h.
The digested PCR product was analyzed by electrophoresis on 2% (wt/vol)
agarose gels.
Recombinant proteins. Polyhistidine-tagged fusion proteins were produced for
use in the immunoblot analyses. S. aureus bap gene and S. epidermidis bhp gene
(AY028618) were PCR amplified (the oligonucleotides used being Sasp-2mN
[5-GGGGGGCATATGGGAAATAAACAAGGTTTTTTACC-3] and Sasp-
3cB [5-GGGGGGATCCCAACCTCGTCAATGGTTAAGTCAGC] for bap
and RP62A-5mN [5-GGAATTCCATATGAAAAATAAACAAGGATTTCTT
CC-3] and RP62A-4c [5-CGATCTTGACTAATAGGGTTTCC] for bhp, with
the NdeI-BamHI sites [underlined]) and cloned downstream from the His tag
sequence in the pET-15b vector (Novagen). Purified plasmid DNA from Esch-
erichia coli DH5 cells was used to transform the expression host BL21(DE3),
and the fusion protein was produced as specified by the manufacturer (Novagen).
After disrupting the cells by sonication, the recombinant protein was purified by
immobilized metal affinity chromatography using a cobalt-based resin (Clon-
tech).
Western blot analysis. The Bap immunoblotting assay was performed as de-
scribed previously (8). Briefly, protein extracts were prepared and analyzed by
sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) (10%
separation gel, 4.5% stacking gel), and blotted onto Immobilon P membrane
(Millipore). The anti-Bap serum was diluted 1:2,500 with Tris-buffered saline
(TBS) (50 mM Tris-HCl [pH 7.5], 150 mM NaCl) and immuno-absorbed with
5% skim milk. As secondary antibodies, alkaline phosphatase-conjugated goat
anti-rabbit immunoglobulin G (Sigma) was used for the anti-Bap serum and
alkaline phosphatase-conjugated rabbit anti-bovine immunoglobulin G (Sigma)
for the bovine sera. Both secondary antibodies were diluted 1:15,000 in TBS–5%
skim milk, and the subsequent chemiluminescence reaction (CSPD; Roche) was
recorded.
Experimental infection. The experimental infection was carried out essentially
by established methods (9). Twenty to 25 days following parturition, each gland
of five healthy lactating ewes was inoculated with 1 ml of a mixed bacterial
suspension containing 2 103 CFU of the Bap-positive V329 strain and the same
amount of the Bap-mutant m556 strain. The lactating mothers were separated
from their suckling lambs 2 h before the bacterial inoculation to ensure the
presence of milk (as a natural lubricant) in the teat duct at the time of inocula-
tion. After the teats were disinfected with 70% ethanol, the bacterial inoculum
was introduced into one gland through a 21-gauge cannula. After inoculation,
since suckling favored a removal of the bacteria, the lambs were separated from
their mothers for 180 min to increase the bacterial colonization of the mammary
gland. Milk samples for the bacteriological analyses were obtained 1, 4, 7, and 14
days after inoculation. Aliquots of the milk samples were placed directly on
blood agar and Congo red agar plates. In addition, to exclude the possibility of
contamination, bacteria recovered at the end of the experimental period were
compared with the parental (inoculated) strains by coagulase DNA typing.
Statistical analysis. A two-tailed Student’s t test was used to determine the
differences in biofilm formation between the groups. A nonparametric test (the
Mann-Whitney U test) was used to assess significant differences within the
groups in bacterial recovery in bovine infections. The log-normalized SCCs for
the clinical groups were compared by means of a one-way analysis of variance
(1). Comparisons between the antibiotic treatment and the control groups were
made with a two-factor analysis of variance (with the help of the Statview
program [version 4.0] for Macintosh), using Scheffe’s F to present the results. For
the analysis of the cure ratio in the experimental infection, a two-by-two contin-
gency table was produced and Fisher’s exact test was applied. Differences were
considered statistically significant when P was 0.05.
RESULTS
Distribution of the genes involved in biofilm formation
among field S. aureus isolates. A PCR analysis using the
icaADBC- and bap-specific primers of 195 bovine mastitis iso-
lates from 13 herds showed that 184 (94.36%) were icaADBC
positive, and 50 of these (25.6%) were also bap positive. All the
bap-positive isolates were also ica positive. The absence of the
icaADBC operon was confirmed by additional Southern blot
analysis with an ica-specific probe (data not shown).
In order to determine whether the different bap or ica pos-
itive isolates could be clonally related, we performed a PCR-
restriction fragment length polymorphism (RFLP) analysis of
the coa gene (20). Ten distinct coa electrophoretic patterns
were observed among the 195 isolates studied (Fig. 1). Based
on the presence or absence of the two loci under study (bap
and ica) and the coa pattern, three groups of isolates were
established: group 1 was bap and ica positive, with all the
isolates of this group showing an identical coa pattern (pattern
I); group 3 was bap and ica negative, with all the isolates of this
group also exhibiting an identical coa pattern (pattern IV);
finally, group 2 was bap negative and ica positive and displayed
different (but never types I and IV) coa patterns.
To determine whether the coa electrophoretic patterns ob-
served in the bovine isolates were also common in staphylo-
cocci from a different host species, a study of the molecular
typing of 50 human S. aureus isolates was carried out; the
resultant patterns differed from the bovine isolates (data not
FIG. 1. RFLP electrophoretic patterns of PCR-amplified coagulase
gene digested with CfoI. The different patterns observed in the analysis
of the bovine S. aureus strains are shown in individual lanes. M,
molecular weight marker (gene ruler 100-bp DNA ladder plus; Fer-
mentas).
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shown). This finding suggests a divergence between S. aureus
isolates of human and bovine origin.
Biofilm formation capacity of S. aureus isolates. Taking into
account the involvement of the ica and bap genes in biofilm
formation, we compared the three groups of S. aureus mastitis
isolates, with regard to biofilm formation capacities. Only
group 1 isolates (bap positive, ica positive, coa pattern I) were
strong biofilm producers (P  0.001 [Fig. 2]). Interestingly,
group 2 isolates, all icaADBC positives, were less able to form
biofilms in our experimental conditions, an inhibition suggest-
ing that genes other than the icaADBC play a major role in the
in vitro biofilm development process of bovine S. aureus iso-
lates. This intriguing result encouraged us to determine
whether the Bap protein was sufficient to induce in vitro bio-
film formation in the absence of the ica operon product. We
generated by allelic exchange a deletion of the ica operon in an
isolate of group 1 (V329). The resulting mutant strain, named
JP38, showed a biofilm formation capacity and Congo red agar
morphology identical to the wild-type isolate, demonstrating
that in the absence of PIA/PNAG, the product of the ica
operon, the expression of the Bap protein is sufficient to induce
biofilm production on abiotic surfaces (data not shown).
bap and ica association with a lower SCC and a higher S.
aureus prevalence. Two studies were carried out to analyze this
association. In the first study, we determined the SCC (geo-
metric and arithmetic means) in milk from animals infected
with group 1, group 2, or group 3 isolates, as well as in unin-
fected control animals. For this purpose, we analyzed 212
glands from animals from one herd (herd E). Considering the
SCC categories established (categories A to D), the mean SCC
of animals infected with isolates of groups 1 and 2 was high
(category C), but was very high for animals infected with iso-
lates of group 3 (category D; P  0.05 [Table 1]). Accordingly,
the SCC values of 13.5% of the animals infected with isolates
of group 1 and 22% of the animals infected with isolates of
group 2 were so low that no evidence of infection was obtained
based on SCC diagnosis (Fig. 3). Similar results were observed
with the CMT (data not shown), indicating that there were
cows naturally infected with S. aureus in groups 1 and 2 which
could not be identified as infected animals by indirect classical
methods (SCC and CMT). This problem was demonstrated by
an isolation of the same clonal type of S. aureus in two con-
secutive milkings from the same animal. Evidently, these indi-
rect classical methods have a low sensitivity for the detection of
infections caused by isolates of groups 1 and 2. These results
also demonstrate that the biofilm-producing isolates (bap and
ica positives) may be unable to cause a significant inflamma-
tion (a neutrophil influx into the milk) and point out the need
for performing a bacteriological analysis rather than a SCC to
detect infection by bap- and ica-positive isolates in milk with a
low SCC.
We then investigated in a second study the possible conse-
quence of omitting the bacteriological analysis and carrying
out only SCC testing on a farm where isolates able to form
biofilm are present. To accomplish this, we classified all the
animals of herd E (450 cows) according to the SCC categories
on two occasions, three months apart; later, we performed a
bacteriological analysis, as well as bap and ica typing in the
same milk samples. On the first occasion, the incidence of
mastitis (milk with 	200 SCC/ml) produced by S. aureus in the
herd was 31, 31, and 38% for groups 1, 2, and 3, respectively.
However, 44 of the noninfected cows according to the SCC
criteria (milk with 200 SCC/ml) were found to be infected by
bacteriological analyses (22 by bap- and ica-positive isolates
and the remaining 22 with ica-positive isolates). On the second
occasion, the rate of occurrence of mastitis (milk with 	200
FIG. 2. Biofilm formation study using S. aureus strains. The types
of S. aureus shown in Fig. 1 were grown overnight in polystyrene
microtiter wells in TSB supplemented with 0.25% glucose. The cells
that adhered to the plate after washing were then visualized by staining
with safranin. Data represent the mean values 
 standard deviations
of triplicate determinations of the increase of bacterial adherence.
Significant differences in adherence (P 0.01) were noted between the
means of strains belonging to coa pattern I and strains belonging to the
other described coa patterns.
FIG. 3. Percentage of animals infected with S. aureus isolates of
groups 1 (bap ica), 2 (bap negative, ica), and 3 (bap negative, ica
negative) among the four SCC categories: very low SCC (A), low-
medium SCC (B), high SCC (C), and very high SCC (D).

















Group 1 36 90 5.88 
 0.50 758 1,330 
 1,666
Group 2 32 77 5.82 
 0.60 660 1,077 
 1,244
Group 3 16 67 6.2 
 0.80 1,585 3,469 
 5,766
Mastitis free 128 128 4.74 
 0.04 53 95 
 107
a GM, geometric mean.
b AM, arithmetic mean.
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SCC/ml) caused by S. aureus in the herd was 36, 50, and 14%
for groups 1, 2, and 3, respectively (the prevalence having
changed at least in part because some infected animals were
sacrificed). However, 24 of the noninfected cows according to
the SCC criteria (milk with 200 SCC/ml) were found to be
infected by the bacteriological tests (18 by bap- and ica-positive
isolates and the remaining 6 with ica-positive isolates). These
results further indicate that cows with a low SCC represent a
reservoir of bacteria with the capacity to form biofilms and
allow the persistence in the farm of isolates of a low early
pathogenicity, a situation obstructing the eradication of S. au-
reus in SCC-based mastitis control programs. Thus, biofilm
formation constitutes a pathogenesis mechanism that helps the
microorganism to survive in the mammary gland and to persist
on the farm.
To discover whether the different strains’ capacities to infect
the mammary gland was a consequence of a varying abilities to
adhere to epithelial cells present in that gland, their adhesion
to 293 cells was studied in vitro. No differences were observed
between the three different strains of S. aureus analyzed from
herd E (strains V329, V299, and V315, corresponding to
groups 1, 2, and 3; data not shown).
Decrease in antibiotic killing effect associated with the pres-
ence of bap and icaADBC genes. It is well-established that
biofilm-grown cells have an increased resistance to antimicro-
bial agents. In order to determine whether biofilm formation
could be one of the reasons for therapy failure in bovine
mastitis, in vitro antimicrobial susceptibility tests were per-
formed using one representative isolate of each group: V329
(group 1), V299 (group 2), and V315 (group 3). As the biofilm
aged from 6 to 24 h, a general decrease in the killing effect was
observed in the three isolates. The killing effect of antibiotics
was lowest in the isolate with the highest capacity to form
biofilms (group 1, bap positive), progressively increased in the
isolate harboring ica but not bap (group 2) and was highest in
the isolate lacking both genes (group 3) (Table 2). In confir-
mation of the biofilm-associated antibiotic resistance, this dif-
ference in susceptibility disappeared when the MIC and MBC
were studied in classical broth microdilution tests (data not
shown).
A rise in biofilm formation and antibiotic resistance was also
observed in isolate V329 (group 1) when compared with its
isogenic bap mutant (m556) (Table 2), a change further sub-
stantiating the role of bap on the decrease in the antibiotic
TABLE 2. Effect of 24-h antibiotic treatments on TSB-grown biofilmsa
Antibiotic Isolate











6 h 24 h 6 h 24 h 6 h 24 h
Cefazolin V329 0.12 28.8* 83.7 2 30.9* 56.2 121 30.9* 72.4
m556 0.12 28.8* 91.2 2 27.5* 66.0 121 16.9* 91.2
V299 1 28.8* 60.2 2 31.6* 100 121 2.6* 100
V315 1 13.1* 58.8 2 2.8* 69.1 121 1.2* 9.1*
Cefuroxime V329 1 39.8* 54.9 4 37.1* 54.9 98 28.8* 74.1
m556 1 3.71* 16.9* 4 3.7* 20.8* 98 4.4* 19.0*
V299 2 18.6* 45.7* 4 12.5* 47.8* 98 13.4* 53.7*
V315 4 13.8* 15.1* 32 15.1* 17.7* 98 3.1* 19.0*
Ciprofloxacin V329 0.12 75.8 72.4 1 100 58.8 2 45.7* 69.1
m556 0.12 69.1 95.4 1 100 91.2 2 37.1* 95.4
V299 0.5 10.2* 61.6 1 7.2* 85.1 2 3.3* 100
V315 0.5 8.12* 53.7* 1 7.5* 61.6 2 1.3* 52.4*
Rifampin V329 0.12 77.6 87.0 0.5 100 77.6 10 2.4* 7.5*
m556 0.12 52.4* 100 0.5 25.1* 75.8 10 1.1* 7.07*
V299 0.5 20.4* 77.6 0.5 20.8* 77.6 10 2.5* 12.8*
V315 0.5 5.37* 28.1* 0.5 5.3* 28.1* 10 1.8* 12.0*
Tobramycin V329 0.25 54.9 56.2 0.5 54.9 54.9 8 43.6* 74.1
m556 0.25 54.9 29.5* 0.5 53.7* 38.0* 8 35.4* 38.0*
V299 4 52.4* 45.7* 4 52.4* 45.7* 8 36.3* 52.4*
V315 1 25.1* 27.5* 2 15.8* 28.8* 8 7.9* 35.4*
Vancomycin V329 2 85.1 64.5 16 100 87.0 40 41.6* 70.7
m556 2 69.1 100 16 32.3* 34.6* 40 11.2* 26.3*
V299 2 95.4 72.4 2 95.4 72.4 40 16.9* 95.4
V315 1 77.6 81.2 2 77.6 83.1 40 7.5* 56.2
a S. aureus isolates V329 (group 1), m556 (Bap mutant), V299 (group 2), and V315 (group 3) were used. Antibiotic concentrations used were the MIC and MBC,
both obtained by classical broth microdilution, and the concentration theoretically reached in serum (PS).
b Measured as percentage of bacterial CFU surviving in the treated samples relative to untreated control samples. Higher percentage of survival means lower
antibiotic killing effect and lower probability of significant differences in bacterial recovery with respect to untreated controls. Higher survival is generally observed in
older (24-h) biofilms. *, significant viability decrease (P  0.05) in the treated versus the untreated control samples in an analysis of variance.
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killing effect. These results strongly suggest that bap-mediated
biofilm formation and not the presence of bap itself is respon-
sible for antibiotic resistance.
Bovine sera contain anti-Bap antibodies. To determine if
the Bap protein is expressed in vivo, the specific antibody
production against Bap in naturally infected cows was ana-
lyzed. A recombinant polypeptide corresponding to the amino-
terminal region of Bap was produced as a soluble hexahisti-
dine-tagged protein in E. coli BL21(DE3) and purified by
affinity chromatography (8). Additionally, a recombinant
polypeptide corresponding to the amino-terminal region of S.
epidermidis Bhp was produced as a negative control. The purity
(	95%) of the isolated recombinant proteins was verified by
SDS-PAGE (data not shown). Serum samples from animals
naturally infected with S. aureus strains were used to probe a
Western blot of the recombinant polypeptides of Bap and Bhp.
Two out of seven sera analyzed from animals infected with
bap-positive S. aureus strains showed antibodies to the Bap
polypeptide (Fig. 4), whereas the three sera analyzed from
animals infected with bap-negative S. aureus strains were un-
reactive. This result suggests that the Bap protein is expressed
during S. aureus infections.
Effect of Bap on persistence of S. aureus in an intramam-
mary gland infection model. Both mammary glands of each of
five animals were experimentally infected to determine the
effect of the presence of Bap on bacterial persistence in ewes’
mastitis. Equal numbers of the Bap-positive strain V329 and
the Bap-negative strain m556 were inoculated together in each
animal. As summarized in Table 3, on day 1 postinoculation,
the animals were infected predominantly with m556 (P 
0.05). Subsequently (days 4, 7, and 14 postinoculation), seven
out of eight mammary glands were infected predominantly
with the V329 strain (Bap-positive; P  0.05). Thus, the pres-
ence of Bap allows the bacteria to persist longer in the mam-
mary glands of the infected animals.
Tandem repeat variation in the C region of bap. The pres-
ence of tandem, highly conserved sequences within the C re-
gion of the bap gene suggested that different staphylococcal
isolates may exhibit variations in the number of repeats as a
result of homologous recombination. To determine if that vari-
ation occurred in vivo, we amplified the C region of the bap
gene from different isolates using the primers sasp-6m and
sasp-9c (Fig. 5A). Subsequently, each of the PCR-amplified
products was restricted with PstI (which cuts once within each
C repeat unit) and the restriction products were analyzed on
2% agarose gel electrophoresis. The PCR amplifications across
the C repeat region revealed substantial variation in the num-
ber of C repeats among the bap-positive isolates. We first
compared two of these Bap-positive isolates (V329 and V858),
and observed a variation in the size of the C region (Fig. 5B).
Evidently, this difference in size corresponded to multiples of
the 258 bp (C repeats), because only three restriction frag-
ments of the expected sizes (1, 140, 258, and 575 bp) were
observed, and the corresponding band intensity in ethidium
bromide-stained gels demonstrated an overrepresentation of
the repeating 258-bp fragment (Fig. 5C). Thus, the deduced
number of C repeats was 13 for the V329 strain and 1 for the
V858 strain. A SDS-PAGE and Western blot analysis of these
strains (strain V329 with 13 C repeats, and strain V858 with 1
C repeat) confirmed the variation in the number of the C
repeats by indicating the presence of Bap proteins with differ-
ent mobilities (Fig. 5D). Further studies on additional bap-
positive strains from the same and other farms confirmed the
variation in the size of the C region, with the number of
deduced C repeat units varying from 1 to 16 (Fig. 5E).
In order to determine whether the number of C repeats
present in Bap was related to the functionality of the protein to
produce biofilm, a comparative study using a standard in vitro
biofilm assay was performed on microtiter plates. No associa-
tion was found between the number of C repeat units within
the bap gene and biofilm formation in the Bap-positive isolates
under the in vitro conditions applied (data not shown).
Stability in the number of C repeats in vivo. A longitudinal
study was carried out in order to determine whether the num-
ber of C repeats in the bacterial bap gene changed during
lactation. Milk from three animals naturally infected with iso-
lates of group 1 (bap positive, ica positive, coa pattern I) was
collected over a 6-month period. Analysis of the C repeat
region revealed that the number of C repeats in the bap gene
changed throughout the study period in isolates obtained from
two of these animals (data not shown). In their bap, ica, and
coa patterns, the isolates of the three animals presented the
phenotype of the bacteria originally recovered from the ani-
mal. Although no evidence for sample contamination or rein-
fections of these three animals was obtained, the possibility
cannot be excluded. In contrast, no changes in the number of
repeats were observed when V329 was subcultured in a labo-
FIG. 4. Western immunoblot of S. aureus Bap (line 1) and S. epi-
dermidis Bhp (line 2) polypeptides with serum samples collected from
two animals with S. aureus mastitis. (A) Serum from a representative
animal among those infected with a bap-positive S. aureus strain. A
similar result was obtained with the other positive sample. (B) Serum
representative of those obtained from animals infected with a bap-
negative S. aureus strain.
TABLE 3. Effect of Bap on persistence of S. aureus in an
intramammary gland infection model
Animal
% Persistencea at postinoculation day:
1 4 7 14
L R L R L R L R
I 50 50 100 90 100 100 100 99
II NI 1 NI 50 NI 80 NI 98
III 1 0 95 0 95 0 100 0
IV 30 30 80 95 100 100 100 100
V NI 1 NI 100 NI 100 NI 100
a Percentage of the V329 (Bap-positive) strain in the mixed population. Milk
samples from the left (L) or right (R) mammary glands were plated on Congo
red agar, and the percentage of rough colonies was calculated. NI, not infected.
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ratory medium over a 2-year period (data not shown), a finding
strongly suggesting that interaction with the host may be a
driving force for the natural selection of bacteria carrying vari-
ant Bap proteins that differ in the number of C repeats.
DISCUSSION
S. aureus bovine mastitis remains a substantial problem for
milk producers worldwide, despite several decades of research
aimed at controlling the disease. It is widely accepted that
mammary gland infection by highly toxigenic strains promotes
the migration of blood neutrophils to the alveolar lumen, con-
sequently increasing the milk SCC and the severity of mastitis.
In previous work, Baselga et al. observed that the severity of
ruminant mastitis decreased but the bacterial capacity to col-
onize the mammary gland increased when the infection was
caused by a mucoid (slime producer) rather than a nonmucoid
S. aureus isolate (4). We later found that the mucoid isolate
used in that study carried bap as well as icaADBC genes (our
unpublished results), both involved in biofilm formation.
In agreement with our previous results, this study showed
that the presence of the two main genetic loci involved in the
biofilm formation process, bap and icaADBC, favored the ap-
pearance of mild infection (13.5 to 22% of the udders) and led
FIG. 5. (A) Schematic representation of the method used to determine the variation in the size of the C region among bap-positive strains. PCR
amplification (B) and PstI digestion of the amplified product (C) of the C region of the V329 (13 C repeats) and V858 (1 C repeat) strains.
(D) Results of the SDS-PAGE and Western blot analysis of the V329 and V858 strains analyzed in panels B and C showing the different size of
the Bap protein. (E) Representation of the variation in the size of the C region among bap-positive strains from different farms (I) or among
bap-positive strains from one individual farm (II).
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to a very low SCC. This situation had important consequences
in milk production at the farm level, as mastitis control inad-
vertently allowed the misclassification of cows as uninfected
when they were in fact infected with ica- and bap-positive
bacteria. These microorganisms remained undetected in the
udder and the infected cows were not submitted to antibiotic
treatment, so that a further spread and persistence of mastitis
in the farm with consequent production losses could take
place. The low SCC associated with a high mammary gland
colonization by some bap-positive ica-positive isolates also sug-
gests a reduced toxin production during these infections. This
reduction could be explained by the finding that bap is carried
by SaPIbov2, an S. aureus pathogenicity island in which the
toxin region has been replaced by a putative composite trans-
poson, including the biofilm-associated protein (bap) gene, an
ABC transporter operon and a transposase (35). The finding
that the bap and toxin genes are located in the same chromo-
somal region suggests that both genes are involved in two
opposite strategies of host-bacterium interactions. On one
hand, bacteria may form biofilms with little or no obvious
harmful effect on the host which are therefore frequently un-
detected. Alternatively, non-biofilm-forming bacteria may pro-
duce toxins, become more pathogenic in the short term, and
cause damage to the host tissues. This may result in an expo-
sure of host adhesins which enable the bacteria to adhere by
interacting with host receptor proteins and to spread to other
body sites.
The early detection of infection should be coupled with
appropriate antimicrobial therapy (28). In this work, we report
experimental evidence that the antibiotic killing effect of some
antibiotics on aged biofilms greatly decreases if the biofilms are
of bap-positive strains (strong biofilm producers). This de-
crease might be enhanced in cows suffering from mastitis, as it
is known that, compared with TSB, milk enhances biofilm
formation (2). Antibiotics to control chronic bovine mastitis
are usually chosen on the basis of conventional in vitro diffu-
sion and dilution evaluation methods and without taking into
account the role of biofilm formation on resistance. As high
concentrations of many known antibiotics are required to kill
biofilm bacteria (3, 30) and lead only to a partial killing effect,
there is a need to find antimicrobials that are efficient against
biofilm bacteria.
The biofilm structure may depend on the nature of the
molecules involved in biofilm formation. Bap comprises a
novel family of proteins, named BAP (for biofilm associated
proteins), which are important for biofilm formation in both
gram-positive and gram-negative bacteria. Members of this
family have been described in S. aureus (Bap) (8), S. epidermi-
dis (Bap and Bhp) (our unpublished results), Enterococcus
faecalis (Esp) (33, 34), Burkholderia cepacia (Bap) (21),
Pseudomonas putida (mus20) (13), and Salmonella enterica se-
rovar Typhimurium (Stm2689) (26). All members of the BAP
family share the following characteristics: (i) a high molecular
weight; (ii) a signal sequence for extracellular secretion; and
(iii) a core domain of repeats, whose number varies among
different isolates. The variation in the length of the Bap C
region detected in this work suggests that the C repeat region
may undergo changes throughout the course of an infection.
Interestingly, a decreased number of repeats affected neither
the functionality of the protein nor the biofilm formation ca-
pacity. We hypothesize that the C region of the Bap might have
a structural function, helping to maintain an elongated protein
conformation at the cell surface. The phase-switching differ-
ences in the C repeat numbers could also be related to an
evasion from the immune response, as observed in the struc-
turally related alpha C protein (24), which undergoes antigenic
variation. The analysis of the amino-terminal region of Bap
and Esp reveals the presence of calcium binding motifs and
dimerization domains, which could promote the interaction of
these proteins with biofilm exopolysaccharides and the inter-
cellular adhesion (two Bap molecules of different bacteria
could undergo dimerization), or could interfere with the staph-
ylococcal adhesion to surfaces and host molecules (9).
It is likely that the presence of Bap reduced infectivity in the
short term by blocking early adherence dependent on host-
MSCRAMM interaction (9) but had the opposite effect in late
adherence, allowing longer bacterial persistence in the mam-
mary gland. The prevalence of the Bap protein itself among the
S. aureus mastitis isolates analyzed changed depending on the
herd and geographic area. Remarkably, Bap can be found
(usually in a small proportion) among bovine mastitis isolates
of different species, including S. aureus, S. epidermidis, Staph-
ylococcus chromogenes, Staphylococcus hycus, and Staphylococ-
cus xylosus, but it is absent from the human Staphylococcus spp.
tested so far (our unpublished results). This difference between
the human and bovine isolates, together with differences be-
tween both isolate sources in PCR-RFLP patterns of the coa
gene, suggest that bovine and human S. aureus isolates are not
clonally related and that specific host-dependent pathogenic
factors may have evolved independently in both species. This
diversity between isolates from different hosts corroborates the
results of Herron et al. (19), who in a preliminary analysis of
the genome of a common clone of bovine S. aureus showed the
presence of numerous genes and sequences that differentiate
this bovine isolate from previously characterized human S.
aureus strains. These differences indicate that a rational and
effective strategy to control IMI caused by bovine-specific iso-
lates may be advantageous.
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